Jeffrey Lancet, MD is interim chair in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, Florida. In this podcast, he talks with Oncology Data Advisor about challenges facing the contemporary management of acute myeloid leukemia, the importance of well-designed clinical trials, and new therapies on the horizon.

Discussion Notes: On challenges of AML treatment and the need for improved clinical trials [1:49] On the most promising recent advances and what we might see at the 2016 ASCO Annual Meeting [3:29] On the risks of bone marrow transplant [5:00]

Jeffrey Lancet, MD is interim chair in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, Florida. In this podcast, he talks with Oncology Data Advisor about challenges facing the contemporary management of acute myeloid leukemia, the importance of well-designed clinical trials, and new therapies on the horizon.

Discussion Notes: On challenges of AML treatment and the need for improved clinical trials [1:49] On the most promising recent advances and what we might see at the 2016 ASCO Annual Meeting [3:29] On the risks of bone marrow transplant [5:00]

Steven Horwitz, MD is an associate professor of medicine at Weill Cornell Medical College and a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. Oncology Data Advisor spoke with Dr. Horwitz at the 2016 Asheville Hematologic Malignancies Symposium about current challenges and new opportunities in the treatment of patients with T-cell lymphoma.

Discussion Notes: Caveats for community oncologists [0:30] On the question Dr. Horwitz most often hears from his patients [2:11] On the greatest challenges facing T-cell lymphoma treatment [3:38] On the most promising recent advances in T-cell lymphoma [4:08]

Mark Socinski, MD, Director of the Lung Cancer Section at the University of Pittsburgh Medical Center, leads a case-based discussion on the contemporary management of non-small cell lung cancer.

Mark Socinski, MD, Director of the Lung Cancer Section at the University of Pittsburgh Medical Center, leads a case-based discussion on the contemporary management of non-small cell lung cancer.